Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytokine-Induced Killer Cells”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Testing effectiveness (Phase 2)UnknownNCT02886897
What this trial is testing

Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaBladder Cancer+3 more
Sun Yat-sen University 50
Early research (Phase 1)Looking for participantsNCT06138587
What this trial is testing

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaLeukemiaLeukemia, Myeloid+3 more
Dana-Farber Cancer Institute 15
Testing effectiveness (Phase 2)UnknownNCT01821482
What this trial is testing

DC-CIK to Treat Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Guangxi Medical University 100
Testing effectiveness (Phase 2)UnknownNCT03736330
What this trial is testing

Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma

Who this might be right for
Renal Cancer Metastatic
Sun Yat-sen University 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02487693
What this trial is testing

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Who this might be right for
Ovarian Carcinoma
The First People's Hospital of Changzhou 50
Early research (Phase 1)Study completedNCT04802070
What this trial is testing

Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.

Who this might be right for
Sarcoma
Prof. Franca Fagioli 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02487550
What this trial is testing

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating

Who this might be right for
Renal Neoplasma
The First People's Hospital of Changzhou 1,200
Testing effectiveness (Phase 2)Study completedNCT03360630
What this trial is testing

Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC

Who this might be right for
Lung CancerNeoplasms
Capital Medical University 60
Testing effectiveness (Phase 2)Study completedNCT00460694
What this trial is testing

Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+4 more
Singapore General Hospital 24
Testing effectiveness (Phase 2)Ended earlyNCT03002831
What this trial is testing

Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic Cancer

Who this might be right for
Advanced Cancer
Henan Cancer Hospital 13
Testing effectiveness (Phase 2)UnknownNCT01799083
What this trial is testing

Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas

Who this might be right for
Solid TumorsB Cell Lymphoma
Han weidong 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT02496988
What this trial is testing

Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas

Who this might be right for
Cytokine-Induced Killer CellsAdvanced Milignant Gliomas
The First People's Hospital of Changzhou 120
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Testing effectiveness (Phase 2)Ended earlyNCT03393858
What this trial is testing

Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma

Who this might be right for
CancerMesothelioma, Malignant
Capital Medical University 10
Testing effectiveness (Phase 2)UnknownNCT03124498
What this trial is testing

Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

Who this might be right for
Hepatocellular Carcinoma
Chuan An Biotechnology Co., Ltd. 55
Very early researchLooking for participantsNCT06643221
What this trial is testing

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

Who this might be right for
LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion+3 more
University of Arizona 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02489890
What this trial is testing

CIK in Treating Patients With Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
The First People's Hospital of Changzhou 1,500
Testing effectiveness (Phase 2)UnknownNCT01924156
What this trial is testing

DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableUnknownNCT04214717
What this trial is testing

Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor

Who this might be right for
Solid Tumor
Yantai Yuhuangding Hospital 60
Not applicableStudy completedNCT01232062
What this trial is testing

Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Peking University Cancer Hospital & Institute 46
Load More Results